ClinicalTrials.govpublic full text
Iclusig® (Ponatinib) in Clinical Practice for the Treatment of Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in Belgium
chronic myeloid leukemia, cml, philadelphia chromosome-positive acute lymphoblastic leukemia, ph+ all, philadelphia chromosome positive acute lymphoblastic leukemia, iclusig®, ponatinib, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 830065
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.